$MFA
MFA FINANCIAL, INC. Stock $mfa

$mfa Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000105516023000010 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$144.4M	$132.2M	$106.3M
YoY Change	32.04%	24.31%	31.21%
Cost Of Revenue	$99.85M	$92.84M	$43.30M
YoY Change	75.96%	114.42%	43.84%
Gross Profit	$7.143M	$98.78M	-$67.69M
YoY Change	-117.12%	-245.94%	-179.35%
Gross Profit Margin	4.95%	74.72%	-63.65%
Selling, General & Admin	$32.94M	$31.02M	$28.25M
YoY Change	11.41%	9.8%	85.88%
% of Gross Profit	461.15%	31.4%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.300M	$1.300M	$3.300M
YoY Change	-60.61%	-60.61%
% of Gross Profit	18.2%	1.32%
Operating Expenses	$42.13M	$41.85M	$38.44M
YoY Change	-44.92%	8.85%	-12914.33%
Operating Profit	-$34.99M	$56.93M	-$106.1M
YoY Change	-70.4%	-153.65%	-223.99%
Interest Expense	$99.85M	$92.84M	$43.30M
YoY Change	75.96%	114.42%	43.98%
% of Operating Profit		163.06%
Other Income/Expense, Net
YoY Change
Pretax Income	-$25.93M	$72.78M	-$82.91M
YoY Change	-74.17%	-187.79%	-196.97%
Income Tax	-$357.0K	$557.0K	$331.0K
% Of Pretax Income		0.77%
Net Earnings	-$25.93M	$72.78M	-$82.91M
YoY Change	-74.17%	-187.79%	-196.94%
Net Earnings / Revenue	-17.96%	55.05%	-77.96%
Basic Earnings Per Share	-$0.34	$0.63	-$0.86
Diluted Earnings Per Share	-$0.34	$0.62	-$0.86
COMMON SHARES
Basic Shares Outstanding	101.9M shares	101.9M shares	106.6M shares
Diluted Shares Outstanding	101.9M shares	110.1M shares	106.6M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$329.4M	$362.5M	$410.9M
YoY Change	-14.58%	-11.8%	-47.38%
Cash & Equivalents	$329.4M	$362.5M	$410.9M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$408.9M	$435.3M	$468.0M
YoY Change	-8.32%	-7.0%	-40.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$38.34M	$38.91M	$39.24M
YoY Change	-1.03%	-0.86%
Goodwill	$61.08M	$61.08M
YoY Change	0.0%
Intangibles	$9.600M	$10.90M	$18.10M
YoY Change	-35.14%	-39.78%
Long-Term Investments	$27.40M	$28.30M	$8.848B
YoY Change	-14.38%	-99.68%	57.91%
Other Assets	$174.0M	$165.1M	$144.6M
YoY Change	8.93%	14.2%	2792.0%
Total Long-Term Assets	$9.327B	$8.876B	$9.457B
YoY Change	3.25%	-6.14%	59.29%
TOTAL ASSETS
Total Short-Term Assets	$408.9M	$435.3M	$468.0M
Total Long-Term Assets	$9.327B	$8.876B	$9.457B
Total Assets	$9.736B	$9.312B	$9.925B
YoY Change	2.71%	-6.18%	47.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$156.6M	$155.9M	$171.7M
YoY Change	0.42%	-9.2%	405.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$223.3M	$191.7M	$547.8M
YoY Change	11.16%	-65.01%	204.33%
LONG-TERM LIABILITIES
Long-Term Debt	$7.568B	$7.101B	$7.028B
YoY Change	6.11%	1.04%	75.88%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$7.568B	$7.101B	$7.028B
YoY Change	6.11%	1.04%	75.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$223.3M	$191.7M	$547.8M
Total Long-Term Liabilities	$7.568B	$7.101B	$7.028B
Total Liabilities	$7.791B	$7.293B	$7.576B
YoY Change	6.25%	-3.74%	81.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.761B	-$1.690B	-$1.417B
YoY Change	12.11%	19.26%	4.07%
Common Stock	$1.019M	$1.019M	$1.050M
YoY Change	0.1%	-2.95%	-76.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.945B	$2.019B	$2.349B
YoY Change
Total Liabilities & Shareholders Equity	$9.736B	$9.312B	$9.925B
YoY Change	2.71%	-6.18%	47.74%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$25.93M	$72.78M	-$82.91M
YoY Change	-74.17%	-187.79%	-196.94%
Depreciation, Depletion And Amortization	$1.300M	$1.300M	$3.300M
YoY Change	-60.61%	-60.61%
Cash From Operating Activities	$77.79M	-$12.67M	$133.6M
YoY Change	1.88%	-109.48%	452.7%
INVESTING ACTIVITIES
Capital Expenditures		$1.458M	$953.0K
YoY Change		52.99%	-78.41%
Acquisitions
YoY Change
Other Investing Activities	-$551.6M	-$140.6M	-$582.5M
YoY Change	236.49%	-75.86%	-266.48%
Cash From Investing Activities	-$550.1M	-$142.1M	-$583.5M
YoY Change	235.05%	-75.64%	-268.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$54.22M
YoY Change			163.74%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	448.1M	$188.3M	$601.0M
YoY Change	477.26%	-68.67%	-248.28%
NET CHANGE
Cash From Operating Activities	77.79M	-$12.67M	$133.6M
Cash From Investing Activities	-550.1M	-$142.1M	-$583.5M
Cash From Financing Activities	448.1M	$188.3M	$601.0M
Net Change In Cash	-24.19M	$33.51M	$151.1M
YoY Change	137.28%	-77.82%	-523.76%
FREE CASH FLOW
Cash From Operating Activities	$77.79M	-$12.67M	$133.6M
Capital Expenditures		$1.458M	$953.0K
Free Cash Flow		-$14.13M	$132.6M
YoY Change		-110.65%	571.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001055160
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2200000	shares
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-13991
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MFA FINANCIAL, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3974868
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Vanderbilt Ave., 48th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	207-6400
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101912357	shares
CY2023Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	7794250000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	7518739000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	504639000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	333364000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362452000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	334183000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	165137000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	159898000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	485129000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	766221000	usd
CY2023Q1	us-gaap	Assets Assets	9311607000	usd
CY2022Q4	us-gaap	Assets Assets	9112405000	usd
CY2023Q1	mfa	Financing Agreements Fair Value And Carrying Value1 FinancingAgreementsFairValueAndCarryingValue1	7101318000	usd
CY2022Q4	mfa	Financing Agreements Fair Value And Carrying Value1 FinancingAgreementsFairValueAndCarryingValue1	6812086000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	191683000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	311470000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	7293001000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	7123556000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	874300000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	874300000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101912000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101912000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101802000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101802000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1019000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1018000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3687285000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3684291000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1690113000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1717991000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	20225000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21341000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2018606000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1988849000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9311607000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9112405000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	119510000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	99466000	usd
CY2023Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	7308000	usd
CY2022Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	5275000	usd
CY2023Q1	us-gaap	Other Operating Income OtherOperatingIncome	2351000	usd
CY2022Q1	us-gaap	Other Operating Income OtherOperatingIncome	1506000	usd
CY2023Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	3036000	usd
CY2022Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	102000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	132205000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	106349000	usd
CY2023Q1	mfa	Interest Expense Asset Backed And Collateralized Financing Agreements InterestExpenseAssetBackedAndCollateralizedFinancingAgreements	88880000	usd
CY2022Q1	mfa	Interest Expense Asset Backed And Collateralized Financing Agreements InterestExpenseAssetBackedAndCollateralizedFinancingAgreements	39365000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3956000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3931000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	92836000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	43296000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	39369000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	63053000	usd
CY2023Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-13000	usd
CY2022Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-3511000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39382000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	66564000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	129174000	usd
CY2022Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	-287935000	usd
CY2023Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	-2931000	usd
CY2022Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	3701000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3942000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	8732000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2022Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	94101000	usd
CY2023Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-51725000	usd
CY2022Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	64117000	usd
CY2023Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	8976000	usd
CY2022Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	14494000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3172000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2676000	usd
CY2023Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	75262000	usd
CY2022Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	-107516000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	20630000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	19556000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	10391000	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8697000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9539000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	10401000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	41860000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	41954000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	64565000	usd
CY2022Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	-91125000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1116000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4977000	usd
CY2023Q1	mfa	Other Comprehensive Income Loss Change In Fair Value Of Financing Agreements At Fair Value OtherComprehensiveIncomeLossChangeInFairValueOfFinancingAgreementsAtFairValue	0	usd
CY2022Q1	mfa	Other Comprehensive Income Loss Change In Fair Value Of Financing Agreements At Fair Value OtherComprehensiveIncomeLossChangeInFairValueOfFinancingAgreementsAtFairValue	-1255000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3722000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	71668000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-86628000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	mfa	Comprehensive Income Loss To Common Stockholders And Participating Securities ComprehensiveIncomeLossToCommonStockholdersAndParticipatingSecurities	63449000	usd
CY2022Q1	mfa	Comprehensive Income Loss To Common Stockholders And Participating Securities ComprehensiveIncomeLossToCommonStockholdersAndParticipatingSecurities	-94847000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1988849000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	599000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3019000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-375000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	35669000	usd
CY2023Q1	mfa	Dividends Dividend Equivalent Rights DividendsDividendEquivalentRights	86000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1116000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2018606000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2542848000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	486000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	55742000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2642000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-76000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.440
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	46215000	usd
CY2022Q1	mfa	Dividends Dividend Equivalent Rights DividendsDividendEquivalentRights	141000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-4977000	usd
CY2022Q1	mfa	Other Comprehensive Income Loss Change In Fair Value Of Financing Agreements At Fair Value OtherComprehensiveIncomeLossChangeInFairValueOfFinancingAgreementsAtFairValue	-1255000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2348955000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2023Q1	mfa	Residential Whole Loans Gain Loss ResidentialWholeLoansGainLoss	129174000	usd
CY2022Q1	mfa	Residential Whole Loans Gain Loss ResidentialWholeLoansGainLoss	-285522000	usd
CY2023Q1	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	2932000	usd
CY2022Q1	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-2921000	usd
CY2023Q1	mfa	Impairment And Other Gains Losses On Securities Available For Sale And Other Assets And Investments ImpairmentAndOtherGainsLossesOnSecuritiesAvailableForSaleAndOtherAssetsAndInvestments	-3936000	usd
CY2022Q1	mfa	Impairment And Other Gains Losses On Securities Available For Sale And Other Assets And Investments ImpairmentAndOtherGainsLossesOnSecuritiesAvailableForSaleAndOtherAssetsAndInvestments	-8249000	usd
CY2023Q1	mfa	Accretion And Amortization Of Purchase Discounts AccretionAndAmortizationOfPurchaseDiscounts	4507000	usd
CY2022Q1	mfa	Accretion And Amortization Of Purchase Discounts AccretionAndAmortizationOfPurchaseDiscounts	4135000	usd
CY2023Q1	mfa	Provision For Reversal Of Credit And Valuation Losses On Residential Whole Loans And Other Financial Instruments At Carrying Value ProvisionForReversalOfCreditAndValuationLossesOnResidentialWholeLoansAndOtherFinancialInstrumentsAtCarryingValue	-4000	usd
CY2022Q1	mfa	Provision For Reversal Of Credit And Valuation Losses On Residential Whole Loans And Other Financial Instruments At Carrying Value ProvisionForReversalOfCreditAndValuationLossesOnResidentialWholeLoansAndOtherFinancialInstrumentsAtCarryingValue	-4038000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-42879000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	99630000	usd
CY2023Q1	mfa	Unrealized Gain Loss On Securitized Debt At Fair Value UnrealizedGainLossOnSecuritizedDebtAtFairValue	-48846000	usd
CY2022Q1	mfa	Unrealized Gain Loss On Securitized Debt At Fair Value UnrealizedGainLossOnSecuritizedDebtAtFairValue	62855000	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	28428000	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-75334000	usd
CY2023Q1	mfa	Other Non Cash Losses Included In Net Income OtherNonCashLossesIncludedInNetIncome	7855000	usd
CY2022Q1	mfa	Other Non Cash Losses Included In Net Income OtherNonCashLossesIncludedInNetIncome	8990000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	27522000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-21997000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11471000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	609000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12668000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	133560000	usd
CY2023Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	459012000	usd
CY2022Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	1192437000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	263014000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	0	usd
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	321626000	usd
CY2022Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	567114000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	305858000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	369000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	5755000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Other Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfOtherInvestments	1470000	usd
CY2023Q1	mfa	Purchase Of Real Estate Owned And Capital Improvements PurchaseOfRealEstateOwnedAndCapitalImprovements	137000	usd
CY2022Q1	mfa	Purchase Of Real Estate Owned And Capital Improvements PurchaseOfRealEstateOwnedAndCapitalImprovements	353000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	33968000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	41336000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1458000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	953000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-142102000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-583454000	usd
CY2023Q1	mfa	Principal Payments On Securities Sold Under Agreements To Repurchase And Other Advances PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchaseAndOtherAdvances	766604000	usd
CY2022Q1	mfa	Principal Payments On Securities Sold Under Agreements To Repurchase And Other Advances PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchaseAndOtherAdvances	586883000	usd
CY2023Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithMarkToMarketCollateralProvisions	640498000	usd
CY2022Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithMarkToMarketCollateralProvisions	965270000	usd
CY2023Q1	mfa	Principal Payments On Financing Agreements With Non Mark To Market Collateral Provisions PrincipalPaymentsOnFinancingAgreementsWithNonMarkToMarketCollateralProvisions	415443000	usd
CY2022Q1	mfa	Principal Payments On Financing Agreements With Non Mark To Market Collateral Provisions PrincipalPaymentsOnFinancingAgreementsWithNonMarkToMarketCollateralProvisions	761122000	usd
CY2023Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Non Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithNonMarkToMarketCollateralProvisions	778400000	usd
CY2022Q1	mfa	Proceeds From Securities Sold Under Agreements To Repurchase With Non Mark To Market Collateral Provisions ProceedsFromSecuritiesSoldUnderAgreementsToRepurchaseWithNonMarkToMarketCollateralProvisions	1096258000	usd
CY2023Q1	mfa	Payments Made For Securitization Related Cost PaymentsMadeForSecuritizationRelatedCost	4602000	usd
CY2022Q1	mfa	Payments Made For Securitization Related Cost PaymentsMadeForSecuritizationRelatedCost	2870000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	581000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	54799000	usd
CY2023Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8219000	usd
CY2022Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	8219000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	35769000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	47230000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	188278000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	600986000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33508000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	151092000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	494081000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	404447000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	527589000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	555539000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	87057000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	34727000	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	20925000	usd
CY2022Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	22079000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35756000	usd
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	46357000	usd
CY2023Q1	mfa	Noncash Payable For Unsettled Loan Purchases NoncashPayableForUnsettledLoanPurchases	0	usd
CY2022Q1	mfa	Noncash Payable For Unsettled Loan Purchases NoncashPayableForUnsettledLoanPurchases	329706000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	Organization <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MFA Financial, Inc. (the “Company”) was incorporated in Maryland on July 24, 1997 and began operations on April 10, 1998. The Company has elected to be treated as a real estate investment trust (“REIT”) for U.S. federal income tax purposes. In order to maintain its qualification as a REIT, the Company must comply with a number of requirements under federal tax law, including that it must distribute at least 90% of its annual REIT taxable income to its stockholders. The Company has elected to treat certain of its subsidiaries as taxable REIT subsidiaries (“TRS”). In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate related business (see Note 8).</span></div>
CY2023Q1	mfa	Number Of Days Considered To Classify Loans Delinquent NumberOfDaysConsideredToClassifyLoansDelinquent	P60D
CY2023Q1	mfa	Ratio Loan To Value RatioLoanToValue	0.80
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362500000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	334200000	usd
CY2023Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	322500000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	267100000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	165100000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	159900000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10900000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12200000	usd
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2023Q1	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	7800000000	usd
CY2022Q4	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	7500000000	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	33061000	usd
CY2022Q4	us-gaap	Allowance For Loan And Lease Losses Real Estate AllowanceForLoanAndLeaseLossesRealEstate	35314000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Residential MortgageLoansOnRealEstateResidential	7794250000	usd
CY2022Q4	mfa	Mortgage Loans On Real Estate Residential MortgageLoansOnRealEstateResidential	7518739000	usd
CY2023Q1	mfa	Residential Whole Loans ResidentialWholeLoans	24052	loan
CY2022Q4	mfa	Residential Whole Loans ResidentialWholeLoans	23843	loan
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35314000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	315000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2567000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	33062000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	39447000	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-3467000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	523000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	35457000	usd
CY2023Q1	us-gaap	Financing Receivable Nonaccrual Interest Income FinancingReceivableNonaccrualInterestIncome	3600000	usd
CY2023Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	0	usd
CY2023Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	0	usd
CY2023Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	63199000	usd
CY2023Q1	us-gaap	Financing Receivable Originated Three Years Before Latest Fiscal Year FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear	226136000	usd
CY2023Q1	us-gaap	Financing Receivable Originated Four Years Before Latest Fiscal Year FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear	603828000	usd
CY2023Q1	us-gaap	Financing Receivable Originated Five Or More Years Before Latest Fiscal Year FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear	859916000	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1753080000	usd
CY2023Q1	mfa	Financing Receivable Year One Originated Current Fiscal Year Writeoff FinancingReceivableYearOneOriginatedCurrentFiscalYearWriteoff	0	usd
CY2023Q1	mfa	Financing Receivable Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	mfa	Financing Receivable Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	mfa	Financing Receivable Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	0	usd
CY2023Q1	mfa	Financing Receivable Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	1598000	usd
CY2023Q1	mfa	Financing Receivable Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	968000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2567000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	21341000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	46833000	usd
CY2023Q1	mfa	Other Comprehensive Income Loss Available For Sale Securities Adjustment Excluding Cumulative Effect Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentExcludingCumulativeEffectNetOfTaxPortionAttributableToParent	-1116000	usd
CY2022Q1	mfa	Other Comprehensive Income Loss Available For Sale Securities Adjustment Excluding Cumulative Effect Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentExcludingCumulativeEffectNetOfTaxPortionAttributableToParent	-4977000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	20225000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	41856000	usd
CY2023Q1	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	0	usd
CY2022Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	275656000	usd
CY2023Q1	us-gaap	Real Estate Investments RealEstateInvestments	121215000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	130605000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	61076000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	61076000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10900000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12200000	usd
CY2023Q1	mfa	Capital Contributions To Loan Origination Partners CapitalContributionsToLoanOriginationPartners	28308000	usd
CY2022Q4	mfa	Capital Contributions To Loan Origination Partners CapitalContributionsToLoanOriginationPartners	28308000	usd
CY2023Q1	us-gaap	Other Interest Earning Assets OtherInterestEarningAssets	59620000	usd
CY2022Q4	us-gaap	Other Interest Earning Assets OtherInterestEarningAssets	63964000	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	72823000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	68704000	usd
CY2023Q1	mfa	Principal Receivable Advances Suspense Accounts And Other PrincipalReceivableAdvancesSuspenseAccountsAndOther	28794000	usd
CY2022Q4	mfa	Principal Receivable Advances Suspense Accounts And Other PrincipalReceivableAdvancesSuspenseAccountsAndOther	23463000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38905000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39459000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	63488000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	62786000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	485129000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	766221000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	17100000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15800000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.075
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	362	property
CY2023Q1	us-gaap	Real Estate Investments RealEstateInvestments	121200000	usd
CY2022Q4	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	388	property
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	130600000	usd
CY2023Q1	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	120900000	usd
CY2022Q4	us-gaap	Real Estate Investments RealEstateInvestments	130605000	usd
CY2021Q4	us-gaap	Real Estate Investments RealEstateInvestments	156223000	usd
CY2023Q1	us-gaap	Real Estate Owned Valuation Allowance Amounts Applied RealEstateOwnedValuationAllowanceAmountsApplied	1052000	usd
CY2022Q1	us-gaap	Real Estate Owned Valuation Allowance Amounts Applied RealEstateOwnedValuationAllowanceAmountsApplied	448000	usd
CY2023Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	20925000	usd
CY2022Q1	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	22079000	usd
CY2023Q1	mfa	Real Estate Investments Additions RealEstateInvestmentsAdditions	137000	usd
CY2022Q1	mfa	Real Estate Investments Additions RealEstateInvestmentsAdditions	353000	usd
CY2023Q1	mfa	Real Estate Investments Disposals RealEstateInvestmentsDisposals	29400000	usd
CY2022Q1	mfa	Real Estate Investments Disposals RealEstateInvestmentsDisposals	32639000	usd
CY2023Q1	us-gaap	Real Estate Investments RealEstateInvestments	121215000	usd
CY2022Q1	us-gaap	Real Estate Investments RealEstateInvestments	145568000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	362	property
CY2022Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	492	property
CY2023Q1	mfa	Number Of Real Estate Properties Sold During Period NumberOfRealEstatePropertiesSoldDuringPeriod	93	property
CY2022Q1	mfa	Number Of Real Estate Properties Sold During Period NumberOfRealEstatePropertiesSoldDuringPeriod	135	property
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	33800000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	41500000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	5000000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	8700000	usd
CY2023Q1	mfa	Expense On Swap Fixed Pay Leg ExpenseOnSwapFixedPayLeg	12034000	usd
CY2022Q1	mfa	Expense On Swap Fixed Pay Leg ExpenseOnSwapFixedPayLeg	5936000	usd
CY2023Q1	mfa	Derivatives Price Alignment Expense On Margin Collateral Received DerivativesPriceAlignmentExpenseOnMarginCollateralReceived	2278000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	28300000	usd
CY2023Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	3000000000	usd
CY2023Q1	us-gaap	Derivative Average Remaining Maturity1 DerivativeAverageRemainingMaturity1	P39M
CY2023Q1	us-gaap	Derivative Remaining Maturity1 DerivativeRemainingMaturity1	P75M
CY2023Q1	mfa	Derivatives Income On Swap Variable Receive Leg DerivativesIncomeOnSwapVariableReceiveLeg	33851000	usd
CY2022Q1	mfa	Derivatives Income On Swap Variable Receive Leg DerivativesIncomeOnSwapVariableReceiveLeg	408000	usd
CY2022Q1	mfa	Derivatives Price Alignment Expense On Margin Collateral Received DerivativesPriceAlignmentExpenseOnMarginCollateralReceived	0	usd
CY2023Q1	us-gaap-supplement	Realized Gain Loss Security Sold Short Operating RealizedGainLossSecuritySoldShortOperating	0	usd
CY2022Q1	us-gaap-supplement	Realized Gain Loss Security Sold Short Operating RealizedGainLossSecuritySoldShortOperating	18876000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2022Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	94101000	usd
CY2023Q1	mfa	Financing Agreements Unpaid Principal Balance FinancingAgreementsUnpaidPrincipalBalance	7282912000	usd
CY2023Q1	mfa	Financing Agreements Fair Value And Carrying Value1 FinancingAgreementsFairValueAndCarryingValue1	7101318000	usd
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0395
CY2022Q4	mfa	Financing Agreements Unpaid Principal Balance FinancingAgreementsUnpaidPrincipalBalance	7043944000	usd
CY2022Q4	mfa	Financing Agreements Fair Value And Carrying Value1 FinancingAgreementsFairValueAndCarryingValue1	6812086000	usd
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0370
CY2023Q1	mfa	Real Estate Investment Trusts Reit Taxable Income Distribution Objective Percent RealEstateInvestmentTrustsREITTaxableIncomeDistributionObjectivePercent	1
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	331000	usd
CY2023Q1	mfa	Repurchase Agreements Number Of Counterparties RepurchaseAgreementsNumberOfCounterparties	14	counterparty
CY2022Q4	mfa	Repurchase Agreements Number Of Counterparties RepurchaseAgreementsNumberOfCounterparties	12	counterparty
CY2023Q1	mfa	Repurchase Agreement Counterparty Risk As Percentage Of Stockholders Equity RepurchaseAgreementCounterpartyRiskAsPercentageOfStockholdersEquity	0.05
CY2023Q1	mfa	Pledged Financial Instruments Not Separately Reported Securities Pledged Aggregate Fair Value And Accrued Interest PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledgedAggregateFairValueAndAccruedInterest	27200000	usd
CY2022Q4	mfa	Pledged Financial Instruments Not Separately Reported Securities Pledged Aggregate Fair Value And Accrued Interest PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledgedAggregateFairValueAndAccruedInterest	30900000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	389200000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-3722000	usd
CY2023Q1	mfa	Payable For Purchase Of Unsettled Securities PayableForPurchaseOfUnsettledSecurities	0	usd
CY2022Q4	mfa	Payable For Purchase Of Unsettled Securities PayableForPurchaseOfUnsettledSecurities	132026000	usd
CY2023Q1	mfa	Dividends And Dividend Equivalents Payable DividendsAndDividendEquivalentsPayable	35756000	usd
CY2022Q4	mfa	Dividends And Dividend Equivalents Payable DividendsAndDividendEquivalentsPayable	35769000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	44726000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	45314000	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	27899000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	23040000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	83302000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	75321000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	191683000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	311470000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	99327000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	97655000	usd
CY2023Q1	mfa	Deferred Tax Assets Unrealized Mark To Market Impairments And Loss Provisions DeferredTaxAssetsUnrealizedMarkToMarketImpairmentsAndLossProvisions	13649000	usd
CY2022Q4	mfa	Deferred Tax Assets Unrealized Mark To Market Impairments And Loss Provisions DeferredTaxAssetsUnrealizedMarkToMarketImpairmentsAndLossProvisions	12609000	usd
CY2023Q1	mfa	Deferred Tax Assets Other Realized Unrealized Treatment Differences DeferredTaxAssetsOtherRealizedUnrealizedTreatmentDifferences	-28061000	usd
CY2022Q4	mfa	Deferred Tax Assets Other Realized Unrealized Treatment Differences DeferredTaxAssetsOtherRealizedUnrealizedTreatmentDifferences	-28620000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84915000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81644000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	84915000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	81644000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-134000	usd
CY2022Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	106000	usd
CY2023Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-53000	usd
CY2022Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	25000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-187000	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	131000	usd
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	589000	usd
CY2022Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	150000	usd
CY2023Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	155000	usd
CY2022Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	50000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	744000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	200000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	557000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	mfa	Effective Income Tax Rate Reconciliation Non Taxable Reit Income Dividends Paid Deduction EffectiveIncomeTaxRateReconciliationNonTaxableREITIncomeDividendsPaidDeduction	-0.090
CY2022Q1	mfa	Effective Income Tax Rate Reconciliation Non Taxable Reit Income Dividends Paid Deduction EffectiveIncomeTaxRateReconciliationNonTaxableREITIncomeDividendsPaidDeduction	0.032
CY2023Q1	mfa	Effective Income Tax Rate Reconciliation Other Differences In Taxable Income Loss From Gaap EffectiveIncomeTaxRateReconciliationOtherDifferencesInTaxableIncomeLossFromGAAP	-0.084
CY2022Q1	mfa	Effective Income Tax Rate Reconciliation Other Differences In Taxable Income Loss From Gaap EffectiveIncomeTaxRateReconciliationOtherDifferencesInTaxableIncomeLossFromGAAP	-0.246
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.029
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.003
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4314000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5751000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4888000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4776000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5055000	usd
CY2023Q1	mfa	Operating Lease Liability To Be Paid After Year Four OperatingLeaseLiabilityToBePaidAfterYearFour	46999000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	71783000	usd
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.35
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	35800000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000	usd
CY2020Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	250000000	shares
CY2023Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2022Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3195769	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	17.15
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	54700000	usd
CY2022Q1	mfa	Payments For Fees Related To Repurchase Of Shares PaymentsForFeesRelatedToRepurchaseOfShares	128000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	202500000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-1116000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1116000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3722000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8219000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	8219000	usd
CY2023Q1	mfa	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	158000	usd
CY2022Q1	mfa	Participating Securities Distributed And Undistributed Earnings Loss Basic And Diluted ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasicAndDiluted	141000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64407000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91266000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101900000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106568000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	64407000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-91266000	usd
CY2023Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	3955000	usd
CY2022Q1	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	158000	usd
CY2022Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	68520000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-91266000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101900000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106568000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	7230000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	956000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110086000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106568000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.62
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4500000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	728000	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3020000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2645000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	6578871000	usd
CY2023Q1	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	2940381000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	6060888000	usd
CY2022Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	2435370000	usd
CY2023Q1	mfa	Other Real Estate Fair Value OtherRealEstateFairValue	20900000	usd
CY2022Q1	mfa	Other Real Estate Fair Value OtherRealEstateFairValue	22100000	usd
CY2023Q1	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	7800000000	usd
CY2022Q4	mfa	Loans Including Fair Value Loans Credit Impaired Loans And Other Loans At Carrying Value LoansIncludingFairValueLoansCreditImpairedLoansAndOtherLoansAtCarryingValue	7500000000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	132205000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	92836000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	39369000	usd
CY2023Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-13000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	39382000	usd
CY2023Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	129174000	usd
CY2023Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	-2931000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	3942000	usd
CY2023Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	-21208000	usd
CY2023Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	-51725000	usd
CY2023Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	8976000	usd
CY2023Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3172000	usd
CY2023Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	75262000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31021000	usd
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9539000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	72784000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2023Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	64565000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	106349000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	43296000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	63053000	usd
CY2022Q1	mfa	Reversal Provision For Credit Losses On Residential Whole Loans ReversalProvisionForCreditLossesOnResidentialWholeLoans	-3511000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	66564000	usd
CY2022Q1	mfa	Mortgage Loans On Real Estate Gain Loss On Loans At Fair Value MortgageLoansOnRealEstateGainLossOnLoansAtFairValue	-287935000	usd
CY2022Q1	mfa	Impairment And Other Losses Gains On Securities Available For Sale And Other Assets ImpairmentAndOtherLossesGainsOnSecuritiesAvailableForSaleAndOtherAssets	3701000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	8732000	usd
CY2022Q1	us-gaap	Gain Loss From Price Risk Management Activity GainLossFromPriceRiskManagementActivity	94101000	usd
CY2022Q1	mfa	Fair Value Changes On Securitized Debt FairValueChangesOnSecuritizedDebt	64117000	usd
CY2022Q1	mfa	Origination Servicing And Other Fee Income OriginationServicingAndOtherFeeIncome	14494000	usd
CY2022Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2676000	usd
CY2022Q1	mfa	Noninterest Income Loss Net NoninterestIncomeLossNet	-107516000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28253000	usd
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	10401000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-82906000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	8219000	usd
CY2022Q1	mfa	Net Income Loss Available To Common Stockholders Basic And Participating Securities NetIncomeLossAvailableToCommonStockholdersBasicAndParticipatingSecurities	-91125000	usd
CY2023Q1	us-gaap	Assets Assets	9311607000	usd
CY2022Q4	us-gaap	Assets Assets	9112405000	usd

Files In Submission

Name	View Source	Status
mfa-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001055160-23-000010-index-headers.html	Edgar Link	pending
0001055160-23-000010-index.html	Edgar Link	pending
0001055160-23-000010.txt	Edgar Link	pending
0001055160-23-000010-xbrl.zip	Edgar Link	pending
exhibit311certificationofc.htm	Edgar Link	pending
exhibit312certificationofc.htm	Edgar Link	pending
exhibit321certificationofc.htm	Edgar Link	pending
exhibit322certificationofc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mfa-20230331.htm	Edgar Link	pending
mfa-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
mfa-20230331_lab.xml	Edgar Link	unprocessable
mfa-20230331_def.xml	Edgar Link	unprocessable
mfa-20230331_pre.xml	Edgar Link	unprocessable
mfa-20230331_htm.xml	Edgar Link	completed
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MFA
MFA FINANCIAL, INC. Stock $mfa

2023 Q2 Form 10-Q Financial Statement

#000105516023000010 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFA MFA FINANCIAL, INC. Stock $mfa

2023 Q2 Form 10-Q Financial Statement

#000105516023000010 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFA
MFA FINANCIAL, INC. Stock $mfa